Shares of Aurobindo Pharma were last trading 2.27 per cent lower at Rs 975.10 on the BSE.Share Price of Aurobindo Pharma Limited edged lower by more than two per cent on Tuesday, June 1, a day after the pharmaceutical company announced its January-March quarter results for the financial year 2020-21.
On Tuesday, Aurobindo Pharma opened on the BSEat Rs 1,000,inching to an intra day high of Rs 1,007.95, and an intra day low of Rs 959.90, through thetrading session so far.
According to a regulatory filing by the firm to the stock exchanges, Aurobindo Pharma reported a net profitof Rs801.18 crore consolidated basis in the fourth quarter of fiscal 2020-21.According to the statement,Aurobindo Pharma reported a consolidated net profit of Rs 863.16 crore for the corresponding quarter of the previous fiscal.
The company's revenue from operations for the March quarter stood at Rs 6,0001.50 crore.
In the same quarter of the previous fiscal, its revenue from operations stood at Rs 6,158.43 crore.The pharma company stated that the net profit after the JV share, minority interest is not comparable due to Natrol divestment.
For the entire financial year 2020-21, Aurobindo Pharma posted a net profit of Rs 5,333.83 crore, compared to a profit of Rs 2,843.67 crore in the year-ago period.On the NSE,Aurobindo Pharma opened at Rs 1,003.01, swinging to an intra day high of Rs 1,008.60, and an intra day low of Rs 959.25, in the session so far.
It was last trading 2.40 per cent at Rs 974 on the NSE.Shares of Aurobindo Pharma were last trading 2.27 per cent lower at Rs 975.10 on the BSE.